ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SRTS Sensus Healthcare Inc

5.9205
0.6205 (11.71%)
After Hours
Last Updated: 22:55:01
Delayed by 15 minutes
Share Name Share Symbol Market Type
Sensus Healthcare Inc NASDAQ:SRTS NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.6205 11.71% 5.9205 6.01 6.12 6.205 5.25 5.26 878,800 22:55:01

Sensus Healthcare to Present at the 20th Annual B. Riley FBR Investor Conference

15/05/2019 1:30pm

PR Newswire (US)


Sensus Healthcare (NASDAQ:SRTS)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Sensus Healthcare Charts.

BOCA RATON, Fla., May 15, 2019 /PRNewswire/ -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced today that Joe Sardano, CEO of the Company, will present a corporate overview at the 20th Annual B. Riley FBR Investor Conference on Thursday, May 23 at 11:00 a.m. Pacific time. The conference will be held May 22-23., 2019 at the Beverly Hilton Hotel in Beverly Hills, Calif.

Mr. Sardano's presentation will be webcast live and available for replay in the Investor Relations section of the Company's website at www.sensushealthcare.com.

About Sensus Healthcare
Sensus Healthcare, Inc. is a medical device company specializing in highly effective, non-invasive, minimally-invasive, and cost-effective treatments for both oncological and non-oncological conditions. The Sculptura™ robotic radiation oncology system provides targeted intraoperative triple-modulated radiotherapy (IORT) and Brachytherapy utilizing our proprietary, state-of-the-art 3D Beam Sculpting™ to treat patients undergoing cancer treatment during surgery, or at the tumor site, with a single dose. Sensus also offers its proprietary low-energy X-ray technology known as superficial radiation therapy (SRT), which is the culmination of more than a decade of research and development, to treat non-melanoma skin cancers and keloids with its SRT-100™, SRT-100+™ and SRT-100 Vision™ systems. With its portfolio of innovative medical device products, Sensus provides revolutionary treatment options to enhance the quality of life of patients around the world.

For more information, visit https://www.sensushealthcare.com.

Investor Contact:
Kim Sutton Golodetz
LHA Investor Relations
(212) 838-3777
kgolodetz@lhai.com

Media Contacts:
Caitlin Kasunich / Brittany Tibaldi
KCSA Strategic Communications
212-896-1241 / 347-487-6794
ckasunich@kcsa.com / btibaldi@kcsa.com  

Cision View original content:http://www.prnewswire.com/news-releases/sensus-healthcare-to-present-at-the-20th-annual-b-riley-fbr-investor-conference-300850490.html

SOURCE Sensus Healthcare, Inc.

Copyright 2019 PR Newswire

1 Year Sensus Healthcare Chart

1 Year Sensus Healthcare Chart

1 Month Sensus Healthcare Chart

1 Month Sensus Healthcare Chart

Your Recent History

Delayed Upgrade Clock